0001530766-14-000007.txt : 20140925 0001530766-14-000007.hdr.sgml : 20140925 20140925113557 ACCESSION NUMBER: 0001530766-14-000007 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140925 DATE AS OF CHANGE: 20140925 EFFECTIVENESS DATE: 20140925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-223449 FILM NUMBER: 141119818 BUSINESS ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310-820-8100 MAIL ADDRESS: STREET 1: 12424 WILSHIRE BOULEVARD STREET 2: SUITE 745 CITY: LOS ANGELES STATE: CA ZIP: 90025 D/A 1 primary_doc.xml X0707 D/A LIVE 0001530766 BioSig Technologies, Inc. 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 310-820-8100 DELAWARE None None Corporation true 2011 Kenneth Londoner 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director Jonathan Steinhouse 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Asher Holzer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Roy Tanaka 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Kalyanam Shivkumar 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Seth Fischer 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Steve Chaussy 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Chief Financial Officer Patrick Gallagher 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Director Gregory Cash 12424 WILSHIRE BOULEVARD SUITE 745 LOS ANGELES CA CALIFORNIA 90025 Executive Officer Director President and Chief Executive Officer Biotechnology Decline to Disclose 06b true 0001530766-14-000006 2014-08-15 false true true false 0 Laidlaw & Company (UK) Ltd. 119037 None None 546 5th Avenue, 5th Floor New York NY NEW YORK 10036 AL ALABAMA AR ARKANSAS CA CALIFORNIA FL FLORIDA IL ILLINOIS KS KANSAS LA LOUISIANA MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK OH OHIO PA PENNSYLVANIA TX TEXAS false 1000000 953000 47000 This represents consideration of $563,000 for securities issued under the Issuer's first closing, occurring on August 15, 2014, and consideration of $390,000 for securities issued under the Issuer's second closing, occurring on September 12, 2014. false 23 46800 0 The Issuer also issued a five-year warrant to purchase 15,600 shares of common stock at an exercise price of $2.75 per share to the placement agent as consideration for serving as the placement agent. 0 false BioSig Technologies, Inc. Gregory Cash Gregory Cash President and Chief Executive Officer 2014-09-25